2CR-21111-38863
4 vaccinations
4 coded responses
37 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
7B6-17458-65615
Child or adolescent in my care · Female · 2022-07-09
X4H-18897-82510
Child or adolescent in my care · Female · 2022-10-27
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
-
2020-12-31
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-02
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-03
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-07
Health check-in — day 7, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-15
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-12
Survey response — day 21, dose 2MedDRA: Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms of retained tissue from miscarriage before first dose (heavy bleeding, cramps, headache)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
-
2021-07-22
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-07-23
-
2021-10-09
Dose 3 — Pfizer-BioNTech
- 2022-01-21
-
2022-04-09
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Dose 4 — ModernaCo-administered: Flu
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-07
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-05
- 2022-11-10
- 2022-12-29
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
| 4 | 2022-09-29 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-01 | priority 2/3 | |
| 2021-01-02 | priority 2/3 | |
| 2021-01-03 | priority 2/3 | |
| 2021-02-12 | Unsuccessful |
Free text
Release 4 — day 21, dose 2
Symptoms: Symptoms of retained tissue from miscarriage before first dose (heavy bleeding, cramps, headache)
Release 9 — 6 months, dose 2
Symptoms: Cold symptoms
Release 11 — 6 months, dose 3
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release